Refine by
Hipaa Articles & Analysis
26 news found
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as they reimagine care for patients living with complex chronic conditions. Bodyport’s focus on the patient has driven them to ...
Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, today announced the appointment of medtech industry veteran, John Lipman, as Chief Executive Officer. Bodyport co-founder, Corey Centen, will continue as President and also serve as Chief Technology Officer (CTO) of the company. Lipman’s appointment comes as Bodyport prepares for ...
Today, at the annual meeting of the American Society of Clinical Oncology (ASCO), Prognos Health and xCures announced a collaboration to enable real-world data access and insights for life science companies across multiple use cases. The multi-year agreement will enable linking and access to xCures de-identified data and Prognos healthcare data marketplace. “We are excited about combining ...
ByxCures
SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing ...
Deep Lens, a digital healthcare company focused on revolutionizing the oncology clinical trial recruitment process through artificial intelligence solutions, today announced the launch of its Real Time Feasibility offering, a new HIPAA-compliant tool designed to identify eligible patients and select the most effective sites in the Deep Lens Unity Network for oncology clinical trials in real-time. ...
Manassas, Virginia (November 30, 2021) - The Notal Vision Monitoring Center celebrates the artificial intelligence (Al) based analysis of the ten millionth test performed by over 20,000 patients with the FDA-cleared ForeseeHome device. The device is part of a comprehensive remote monitoring service for intermediate age-related macular degeneration (AMD) patients at risk of developing the sight ...
Avail Medsystems, whose audio/video technology fosters medical education and cooperation through live interactive broadcasts from the operating room, and BIOMODEX, the leader in biorealistic haptic simulators for physician training and rehearsals, have announced a new collaboration that takes virtual medical education to the next level. The partnership will enable physician groups, health ...
ByBIOMODEX
EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s technology received FDA approval on July 27, 2021 Us2.ai’s software is being ...
AZOVA Inc., creator of the world’s most comprehensive digital health network for COVID-19 testing and vaccination management, and Ellume, the company to bring the first non-prescription over-the-counter COVID-19 home test to market, today announced an official partnership with Alaska Airlines to provide a convenient, at-home rapid testing solution for its passengers. The Ellume COVID-19 ...
At first glance, the news that the federal public health emergency will remain in place through the remainder of 2021 might seem like a bad sign for hopes of quickly beating back COVID-19 and finally returning to normal. But it’s also good news for the continued growth of telehealth, and for patients. Norris Cochran, the acting secretary of the U.S. Department of Health and Human ...
A newly expanded Direct-to-Patient service offering supports decentralized clinical trials to minimize clinical trial length and costs while maximizing patient enrollment and participation rates. The comprehensive offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable clinical trial medication delivery directly to patients' homes. Thermo ...
MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. Virtual attendees of The MedTech Conference, the largest gathering of medtech industry leaders in North America, powered by AdvaMed, will vote online to choose the ...
Electroencephalography (EEG) devices are incredibly helpful in diagnosing and monitoring certain brain disorders, such as epilepsy and strokes. However, they are not particularly user-friendly or convenient, with specialized technicians performing time consuming procedures, such as skin preparation, to get patients ready to undergo the procedure. A combination of messy gels and wires also makes ...
RemetricHealth, a leading remote patient monitoring (RPM) and telehealth services company that has been serving the healthcare industry for more than a decade, has announced that its telehealth capabilities, in conjunction with its biometric monitoring devices, are helping connect patients and providers in a time when continuity of care can be challenging due to COVID-19. The telehealth model is ...
IRVINE, Calif., May 28, 2020 (Newswire.com) - betweenMD is very excited to announce our partnership with Oxitone, makers of the world's first FDA-cleared risk monitoring device. Oxitone developed a wearable monitoring device, specifically designed and FDA-cleared for in-home use for patients with respiratory failure. This unique solution is for prolonged monitoring for those at risk for ...
We deeply thank you for the service you do for the society and for the essential care you provide to pregnant mothers across the US amid this unprecedented pandemic. Our hearts and thoughts go to all of you–you and your family, your clinic staff members, your patients–who have been affected by COVID-19. As a fellow healthcare provider, our team shares the concerns that many of you are ...
Our Refurbished Accsense A2-05 Temperature Monitoring Systems and our Demo Accsense Wireless Monitoring Systemsare 25% off now through January 31, 2019. While supplies last. Refurbished and 100% tested, they are the ideal solution for the temperature monitoring and alarming needs of clinics, health departments, hospital pharmacies, and other healthcare facilities around the world. Accsense ...
Gauss Surgical, Inc. announced today that the company has received CE (Conformité Européenne) Mark for its Triton System™ for iPad, the world’s first and only mobile platform for real-time monitoring of surgical blood loss. This milestone allows Gauss to market and sell its system throughout Europe and other regions that require the CE Mark. Additionally, the company ...
Gauss Surgical, Inc. announced today that the company will compete in the annual “UHC Startup Challenge”, which will take place on Friday, October 2 in Orlando as part of the “Advance: UHC Annual Conference 2015”. The company will have the opportunity to present Triton, the world’s first and only mobile platform for real-time monitoring of surgical blood loss, to the ...